146 related articles for article (PubMed ID: 37926772)
1. A prospective study of
Shamim SA; Kumar N; Arora G; Jaswal S; Shalimar ; Gamanagatti S; Bal C
Ann Nucl Med; 2024 Feb; 38(2):103-111. PubMed ID: 37926772
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. [
Kunikowska J; Cieślak B; Gierej B; Patkowski W; Kraj L; Kotulski M; Zieniewicz K; Królicki L
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):883-892. PubMed ID: 32885272
[TBL] [Abstract][Full Text] [Related]
4. Potential role of
Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
[TBL] [Abstract][Full Text] [Related]
5. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and
Thompson SM; Suman G; Torbenson MS; Chen ZE; Jondal DE; Patra A; Ehman EC; Andrews JC; Fleming CJ; Welch BT; Kurup AN; Roberts LR; Watt KD; Truty MJ; Cleary SP; Smoot RL; Heimbach JK; Tran NH; Mahipal A; Yin J; Zemla T; Wang C; Fogarty Z; Jacobson M; Kemp BJ; Venkatesh SK; Johnson GB; Woodrum DA; Goenka AH
Hepatol Commun; 2022 May; 6(5):1172-1185. PubMed ID: 34783177
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
7.
Hirmas N; Leyh C; Sraieb M; Barbato F; Schaarschmidt BM; Umutlu L; Nader M; Wedemeyer H; Ferdinandus J; Rischpler C; Herrmann K; Costa PF; Lange CM; Weber M; Fendler WP
J Nucl Med; 2021 Sep; 62(9):1235-1241. PubMed ID: 33509970
[TBL] [Abstract][Full Text] [Related]
8.
Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
[No Abstract] [Full Text] [Related]
9. Combined Utility of
Kalapara AA; Ballok ZE; Ramdave S; O'Sullivan R; Ryan A; Konety B; Grummet JP; Frydenberg M
Eur Urol Oncol; 2022 Jun; 5(3):314-320. PubMed ID: 33741337
[TBL] [Abstract][Full Text] [Related]
10. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [
Lv J; Yu H; Yin H; Shi Y; Shi H
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):919-927. PubMed ID: 37940684
[TBL] [Abstract][Full Text] [Related]
11. Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
Bodar YJL; Veerman H; Meijer D; de Bie K; van Leeuwen PJ; Donswijk ML; van Moorselaar RJA; Hendrikse NH; Boellaard R; Oprea-Lager DE; Vis AN
BJU Int; 2022 Jun; 129(6):768-776. PubMed ID: 35166426
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
[TBL] [Abstract][Full Text] [Related]
13.
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
[TBL] [Abstract][Full Text] [Related]
14. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [
Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
[TBL] [Abstract][Full Text] [Related]
16. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT.
Kuyumcu S; Has-Simsek D; Iliaz R; Sanli Y; Buyukkaya F; Akyuz F; Turkmen C
Clin Nucl Med; 2019 Sep; 44(9):702-706. PubMed ID: 31348076
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
[TBL] [Abstract][Full Text] [Related]
18. Incremental Impact of [
Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
[TBL] [Abstract][Full Text] [Related]
19. Prospective Evaluation of
Lopci E; Lughezzani G; Castello A; Saita A; Colombo P; Hurle R; Peschechera R; Benetti A; Zandegiacomo S; Pasini L; Casale P; Pietro D; Bevilacqua G; Balzarini L; Buffi NM; Guazzoni G; Lazzeri M
Eur Urol Focus; 2021 Jul; 7(4):764-771. PubMed ID: 32312701
[TBL] [Abstract][Full Text] [Related]
20.
De Man K; Van Laeken N; Schelfhout V; Fendler WP; Lambert B; Kersemans K; Piron S; Lumen N; Decaestecker K; Fonteyne V; Delrue L; De Vos F; Ost P
Eur Urol; 2022 Nov; 82(5):501-509. PubMed ID: 35690515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
